CITIC M&A Fund and Legend Capital have agreed to lead an investor consortium to invest US$280 million in Pharmaron, a contract research organization (CRO) for the pharmaceutical industry, according to an announcement.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?